* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Frequency of spontaneous and inducible atrioventricular nodal
Electrocardiography wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Ventricular fibrillation wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Frequency of Spontaneous and Inducible Atrioventricular Nodal Reentry Tachycardia in Patients with Idiopathic Outflow Tract Ventricular Arrhythmias IAN TOPILSKI, AHARON GLICK, SAMI VISKIN, and BERNARD BELHASSEN From the Department of Cardiology, Tel-Aviv Sourasky Medical Center, and the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel TOPILSKI, I., ET AL.: Frequency of Spontaneous and Inducible Atrioventricular Nodal Reentry Tachycardia in Patients with Idiopathic Outflow Tract Ventricular Arrhythmias. Objectives: We sought to assess the frequency of spontaneous or inducible atrioventricular nodal reentry tachycardia (AVNRT) in patients referred for radiofrequency ablation (RFA) of idiopathic outflow tract ventricular arrhythmias. Background: In patients with no obvious heart disease, AVNRT and outflow tract ventricular tachycardia (VT) are the most frequently encountered supraventricular and ventricular tachycardias, respectively. An increased coexistence of the two arrhythmias has been recently suggested. Methods: In 68 consecutive patients referred for RFA of an idiopathic ventricular outflow tract arrhythmia, a stimulation protocol including repeated bursts of rapid atrial pacing, up to triple atrial extrastimuli during sinus rhythm and rapid ventricular pacing was performed before and after isoproterenol infusion following RFA of the ventricular arrhythmia. In patients with inducible AVNRT, RFA of the slow pathway was performed. Results: Of the 68 study patients, 17 (25%) had either spontaneous AVNRT documented prior to RFA of the ventricular arrhythmia (n = 4) or inducible AVNRT at the time of RFA of the ventricular arrhythmia (n = 13). AVNRT was induced by atrial pacing in 15 (88%) of 17 patients: in 3 patients without isoproterenol and in 12 patients during isoproterenol infusion. Uncomplicated RFA of the slow pathway was successfully achieved in all patients with inducible AVNRT. Conclusion: Spontaneous or inducible AVNRT is relatively common in patients with idiopathic outflow tract ventricular arrhythmias. Atrial stimulation, especially when performed after isoproterenol infusion plays a major role in AVNRT inducibility. Although we performed RFA of the slow pathway in patients with inducible AVNRT and no prior tachycardia documentation, the question whether this is mandatory remains unsettled. (PACE 2006; 29:21–28) AV nodal reentry tachycardia, outflow tract ventricular arrhythmias, radiofrequency ablation Introduction Early reports documented the rare coexistence of supraventricular tachycardia and ventricular tachycardia (VT) in the same patient, occurring mainly in patients with organic heart disease and digitalis toxicity.1–3 Later reports have suggested such an association in patients with no obvious heart disease4–10 where the most frequent combination consisted of atrioventricular nodal reentry tachycardia (AVNRT) and either right or left outflow tract VT.7,9,10 In the present study, we assessed the prevalence of spontaneous or inducible AVNRT in consecutive patients referred for radiofrequency ablation (RFA) of idiopathic outflow tract ventricular arrhythmias. Address for reprints: Bernard Belhassen, M.D., Department of Cardiology, Tel-Aviv Sourasky Medical Center, Weizman St, 6 Tel-Aviv 64239, Israel. Fax: 00-972-3-697-4418; e-mail: [email protected] Received August 16, 2005; revised September 27, 2005; accepted September 27, 2005. Patients and Methods Patients The study group consisted of 68 consecutive patients referred for RFA of ventricular ectopy or tachycardia originating from the right ventricular (RV) or left ventricular (LV) outflow tract during a 6-year period (1999–2004). None of the patients had structural heart disease based on physical examination, resting ECG, and echocardiogram (the existence of minimal segmental LV contraction abnormalities was tolerated). Methods The electrophysiologic studies were performed after informed consent by standard methods using two- or three-electrode catheters introduced through the right femoral vein. In patients with spontaneous ventricular arrhythmias RFA was attempted first, using conventional mapping techniques. In patients without spontaneous ventricular arrhythmias, induction of the ventricular arrhythmia was attempted with repeated bursts of rapid right atrial pacing, atrial extrastimulation C 2006, The Authors. Journal compilation C 2006, Blackwell Publishing, Inc. PACE, Vol. 29 January 2006 21 TOPILSKI, ET AL. using up to triple extrastimuli during sinus rhythm and bursts of rapid RV pacing, first in the baseline state and then (in noninducible patients) during isoproterenol infusion. After ablation of the ventricular arrhythmia, the previously described pacing protocol was repeated (with and without isoproterenol) to induce AVNRT. Whenever AVNRT was induced, ablation of the slow AV nodal pathway was performed using conventional techniques. In patients who had easily inducible AVNRT that interfered with ablation of the ventricular arrhythmia, RFA of the slow pathway was performed first. Definitions An arrhythmia was defined as sustained if it lasted ≥30 seconds, and nonsustained if it lasted >6 beats but <30 seconds. Statistical Analysis Values were expressed as mean ± standard deviation. A Student’s t-test was used to compare parametric data. The χ 2 test was used to compare nonparametric data. P value <0.05 was considered statistically significant. Results Overall Results Of the 68 patients who underwent RFA of their outflow tract ventricular arrhythmias, 17 (25%) had either spontaneous AVNRT documented prior to ablation of the ventricular arrhythmia or inducible AVNRT during the stimulation protocol. Clinical Characteristics of the Patients with “Double Arrhythmia” There were 12 women and 5 men, aged 18–74 years (mean 46.5 ± 16). Most patients (n = 16) suffered from recurrent palpitations felt to have different rates by 1 patient (#7). One patient (#16) was asymptomatic and had his ventricular arrhythmia diagnosed during routine exercise test. Symptoms duration ranged from a few weeks to 20 years (mean 58 ± 67 months) (Table I). Spontaneous Ventricular Arrhythmias The clinically documented ventricular arrhythmia was sustained VT in 3 patients, nonsustained VT in 8 patients (including a repetitive form in 3) and only couplets and triplets in the remaining 6 patients. In 9 patients the ventricular TABLE I. Baseline Symptoms and Clinical Tachycardia Patient 1 2 3* 4 5 6† 7 8† 9 10 11 12 13 14 15 16 17* Gender Age Symptoms Spontaneous Arrhythmias (rate in beats/min) M M F F M F F F F F M F F F F M F 64 53 29 52 72 56 40 30 55 25 38 57 74 51 49 18 28 Palpitations Palpitations Palpitations + syncope (pregnant) Palpitations Palpitations Palpitations + syncope Palpitations of two types Palpitations Palpitations Palpitations Palpitations Palpitations Palpitations + chest pain Palpitations Palpitations + dizziness Asymptomatic Palpitations LVOT-HGVA RVOT-NSVT (repetitive) (EET) RVOT-SUVT + AVNRT(250) RVOT-NSVT LVOT-HGVA RVOT-SUVT +AVNRT (220) RVOT-HGVA RVOT-NSVT (repetitive)† AVNRT(260) RVOT-HGVA RVOT-SUVT RVOT-HGVA RVOT-SUVT RVOT-NSVT RVOT-NSVT (repetitive) RVOT-NSVT RVOT-NSVT RVOT-HGVA + AVNRT VT Rate (beats/min) 200 190 230 220–260 240 250 230 150 160 170 150 AVNRT = atrioventricular nodal reentry tachycardia; ET = exercise test; F = female; HGVA = high-grade ventricular arrhythmias; LVOT = left ventricular outflow tract; M = male; NSVT = nonsustained VT; RVOT= right ventricular outflow tract; SUVT = sustained VT. *Patients #3 and #17 had documented and inducible AVNRT during radiofrequency ablation of the slow pathway performed 4 years (#3) and 14 months (#17) prior to ablation of the ventricular arrhythmia. † Patients #6 and #8 had spontaneously documented and inducible AVNRT at the time of radiofrequency ablation of the ventricular arrhythmia. 22 January 2006 PACE, Vol. 29 AVNRT AND OUTFLOW TRACT VENTRICULAR ARRHYTHMIAS arrhythmia occurred without any obvious precipitating cause while in 8 patients it was precipitated by exercise or stress. The spontaneous VT rate ranged from 150 to 260 (mean 201 ± 39) beats/min. Previously Documented AVNRT Four of the above 17 patients (#3, #6, #8, #17) had spontaneous AVNRT documented prior to RFA of the ventricular arrhythmia. Two of these patients (#3, #17) underwent successful RFA of AVNRT 4 years and 14 months, prior to RFA of the ventricular arrhythmia. In the other 2 patients (#6 and #8) spontaneous double tachycardia (VT and AVNRT) was documented. In patient #6, VT (220–260/min) and AVNRT (220/min) were documented during exercise testing with AVNRT following termination of VT (Fig. 1). In patient #8 both spontaneous VT (240–260/min) initiating AVNRT (220/min) as well as initiation of AVNRT during VT were documented during symptomatic episodes (Fig. 2). The remaining 13 patients had AVNRT documented only during the electrophysiologic study for RFA of their ventricular arrhythmias. There was no correlation between the symptoms, type of clinical tachycardia, and rate of tachycardia. In the single patient (#7) who complained of two types of palpitations, only one type of tachycardia (VT) was spontaneously documented. Electrophysiological Results AVNRT was induced before isoproterenol infusion in 3 patients: in 2 patients (#5, #6) with atrial pacing, and in 1 patient (#16) with both atrial and ventricular pacing (Fig. 3). In the remaining 14 patients AVNRT was induced after isoproterenol infusion: in 12 patients during atrial pacing and in 2 during ventricular pacing (Table II). Induced AVNRT was sustained in 15 patients (88%) and nonsustained (but lasting ≥15 seconds) in 2 (12%). AVNRT rate ranged from 150 to 260 (mean 200 ± 34) beats/min but was not correlated with the induced (r = 0.46, P = NS) or spontaneous VT rate (r = 0.45, P = NS). In 1 patient (#8), nonsustained RV outflow tract tachycardia was documented during AVNRT induced with atrial and ventricular pacing during isoproterenol (Fig. 4). Figure 1. Patient #6. A 56-year-old woman with double tachycardia induced during exercise testing. During the immediate recovery phase, VT (260/min) was initiated and terminated 20 seconds later after a slight rate slowing (220/min). At VT termination, a sustained AVNRT was observed (220/min). No fusion beats were observed during VT or AVNRT. PACE, Vol. 29 January 2006 23 TOPILSKI, ET AL. Figure 2. Patient #8. A 30-year-old woman with spontaneously documented double tachycardia at admission to the hospital for palpitations. Standard ECG leads are shown. Rapid VT (260/min) occurred during sinus rhythm and terminated 4.5 seconds later after slight slowing (240/min) of the tachycardia rate; a few beats of AVNRT (220/min) then followed. A similar sequence of events was subsequently observed while VT and AVNRT rates were similar (220/min). Several fusion beats were observed suggesting that both tachycardias were occurring simultaneously. Results of Catheter Ablation Ventricular Arrhythmias In 2 (12%) patients (#1, #5) in whom the origin of the ventricular arrhythmia was felt to be in the LV outflow tract or a coronary cusp, RFA was not attempted. Catheter ablation of the ventricular arrhythmia was acutely successful in all the other 15 (88%) patients. The successful ablation sites in the RV outflow tract were located at the anteroseptal area (7 patients), posteroseptal area (4 patients), and midseptal area (4 patients). AVNRT Ablation of the slow AV nodal pathway was successfully performed without complications in all 17 patients with inducible AVNRT. In addition to the 2 patients (#3, #17) who underwent ablation of AVNRT 4 years and 14 months before the ablation of the ventricular arrhythmia, 7 patients underwent slow pathway ablation before ablation of the ventricular arrhythmia while the remaining 8 patients underwent slow pathway ablation after ablation of the ventricular arrhythmia. Discussion Association Idiopathic VT-AVNRT The association between idiopathic VT and AVNRT was first described by our group more than 20 years ago.4 Both arrhythmias were induced during electrophysiologic study but only VT (originating from the LV) had been clinically documented before study. Four other case reports 24 have documented the association of idiopathic VT and AVNRT: VT originated from the LV in 2 patients5,6 and in the RV outflow tract in the other 2 patients.7,9 In 2 cases, VT was the only clinically documented arrhythmia6,9 while in the 2 others both VT and AVNRT were documented.5,7 Induction of both tachycardias was observed during electrophysiologic study in all 4 patients. Recently Kautzner et al.10 reported the first systematic study assessing the induction of AVNRT in patients with idiopathic outflow tract VT (most originating in the RV). They found that 7 (15%) of 46 patients with VT developed reproducible AVNRT during electrophysiologic study. However, none of these 7 patients had documented prior AVNRT. In the present study, we found a higher incidence (25%) of inducible AVNRT in a series of 68 consecutive patients referred for ablation of an idiopathic ventricular outflow tract arrhythmia. Interestingly, 4 (23.5%) of the 17 patients with inducible AVNRT also had the same arrhythmia clinically documented. Dual AV nodal pathways are frequently observed during electrophysiologic evaluation of patients without spontaneous AVNRT, especially in heavily sedated patients.11 However, AVNRT is rarely induced in such patients, even after administration of isoproterenol and atropine. We also reviewed our data (1999–2004) on AVNRT induction in a group of 252 consecutive patients with no heart disease after successful RFA of an accessory pathway. The stimulation protocol was similar to that of the present study including rapid atrial January 2006 PACE, Vol. 29 AVNRT AND OUTFLOW TRACT VENTRICULAR ARRHYTHMIAS Figure 3. Patient #16. An 18-year-old man with asymptomatic spontaneous catecholamine sensitive VT. During baseline electrophysiologic study, no ventricular arrhythmias were observed; however, AVNRT (170/min) was easily induced with atrial stimulation and therefore RFA of slow pathway was performed first. After slow pathway ablation, and during isoproterenol infusion, sustained VT (150/min) spontaneously occurred and was ablated at the posteroseptal area of the RV outflow tract (note that the early R/S transition in V2 rather suggests a VT origin in the LV outflow tract or a coronary cusp). After VT ablation, extensive atrial and ventricular pacing before and after isoproterenol failed to induce any type of tachycardia. pacing, atrial extrastimulation and rapid ventricular pacing before and after isoproterenol infusion. We induced AVNRT in 17 (6.7%) of the 252 patients ( P < 0.005 as compared to the induction rate in the present study). Josephson reported a similar inducibility rate of AVNRT (8–10%) in patients with concealed or manifest accessory pathways.12 In contrast the induction rate of AVNRT in our patients with idiopathic outflow tract ventricular arrhythmias was much higher, yet reports of this association are scanty. This discrepancy could be explained by the relatively aggressive protocol of atrial stimulation used in our study (that included repeated bursts of rapid right atrial pacing and PACE, Vol. 29 the application of up to triple atrial extrastimuli, before and after isoproterenol infusion). Indeed, AVNRT could be induced in 15 of 17 patients with atrial pacing, in most cases (13/15) during isoproterenol infusion. Possible Mechanisms for the AVNRT-VT Coexistence There are several possible explanations for the frequent association of these two arrhythmias as observed in our study. The first is a random coexistence of these two frequently encountered arrhythmias. However, the 25% incidence of AVNRT January 2006 25 TOPILSKI, ET AL. TABLE II. EPS and RF Ablation Results Patient VT Characteristics 1 2 3* 4 5 6† 7 8† 9 10 11 12 13 14 15 16 17* SUVT NSVT HGVA NSVT HGVA HGVA Noninducible NSVT HGVA HGVA HGVA NSVT NSVT NSVT NSVT NSVT HGVA AVNRT Induction AVNRT Rate (beats/min) First Ablated Arrhythmia RA pacing + isoproterenol RA pacing + isoproterenol RA pacing + isoproterenol RV pacing + isoproterenol RA pacing RA pacing RA pacing + isoproterenol RA & RV pacing + isoproterenol RA pacing + isoproterenol RV pacing + isoproterenol RA pacing + isoproterenol RA pacing + isoproterenol RA pacing + isoproterenol RA pacing + isoproterenol RA pacing + isoproterenol RA pacing + RV pacing RA pacing + isoproterenol 170 180 240 190 150 150 200 230 250 200 260 230 210 220 160 170 190 AVNRT (VA not ablated) VA AVNRT VA AVNRT (VA not ablated) AVNRT AVNRT AVNRT VA AVNRT VA VA VA VA VA AVNRT AVNRT RA = right atrium; RV = right ventricle; VA = ventricular arrhythmia; other abbreviations as in Table I. found in our VT patient population as compared to the 6.7% incidence found in patients undergoing accessory pathway ablation argues against such a mere random coexistence. A second possible explanation is that VT is induced by AVNRT. This was observed in one patient (#8) both spontaneously (Fig. 2) and at electrophysiologic study during isoproterenol infusion (Fig. 4). One may suspect that this patient had outflow tract VT due to c-AMP-mediated triggered activity that could be induced by rapid heart rhythm resulting from AVNRT in the presence of adrenergic stimulation. Kautzner et al.10 reported 3 patients with a similar mode of induction. The fact that the ventricular arrhythmia could be induced only at rapid, narrow ranges of AVNRT rates (230–260/min) as well as the similar VT and AVNRT rates further support that mechanism. A third possible explanation of our results is that AVNRT is induced by VT. This was observed in 2 patients (#6, #8) either spontaneously or during exercise testing (Figs. 1 and 2). The fact that a similar induction of AVNRT was achieved following rapid ventricular pacing in 2 other patients (#4, #10) gives further support to that explanation. This implies retrograde conduction in the fast pathway during the ventricular rhythm just before AVNRT initiation. Similar cases were previously reported.7,9,10 Finally, the fourth possible explanation was raised by Kautzner et al.10 who hypothesized that patients with coexistent outflow tract ventricular arrhythmias and 26 AVNRT may have more abundant specialized myocytes both in the perinodal area and in the outflow tract.13,14 In any case, sympathetic stimulation seemed to play an important role both in facilitating delayed afterdepolarization-mediated triggered activity (assumed to be responsible for outflow tract ventricular arrhythmias) and conduction in the antegrade and retrograde limbs of the AV nodal circuit. Study Limitations Our study does not answer the interesting question whether AVNRT should be ablated in patients without previous clinical documentation since we ablated the slow pathway in all our 17 patients with inducible AVNRT, including the 13 patients who did not have spontaneous documentation of this tachycardia. We elected to ablate the slow pathway for two main reasons: (a) AVNRT is rarely induced in patients who do not exhibit this arrhythmia clinically, and (b) RFA ablation of slow pathway is associated with a high success rate. However, we recognize that a conservative attitude could also have been justifiable, deferring RFA to the occasional patient who later develops symptomatic tachycardia, because: (a) the prognostic clinical significance of inducible AVNRT in patients without previously documented tachycardias is uncertain; (b) RFA of slow pathway is associated with a minimal but definite risk of complications such as AV block; (c) it may be difficult to January 2006 PACE, Vol. 29 AVNRT AND OUTFLOW TRACT VENTRICULAR ARRHYTHMIAS Figure 4. Same patient as in Figure 2. Nonsustained VT occurred during AVNRT previously induced with rapid atrial pacing during isoproterenol infusion. Note the similarity of the cycle lengths of AVNRT and VT and the presence of several fusion beats. His = His bundle electrogram activity; HRA = high right atrial electrogram. obtain a “true” informed patient consent for ablation of slow pathway during the course of RFA of a ventricular arrhythmia though this study suggests that such a minimum consent should be obtained in most patients. Only a randomized study can answer the question if patients who underwent slow pathway ablation will have a benefit from the additional ablation of this undocumented (and perhaps not clinical) tachycardia or not. Conclusion Our study describes an unexpected high incidence of the coexistence of spontaneous or induced AVNRT and idiopathic ventricular outflow tract arrhythmias and this mandates a search for AVNRT in patients undergoing electrophysiologic assessment of outflow tract ventricular arrhythmias. The stimulation protocol including atrial stimulation before and after isoproterenol infusion plays a major role in AVNRT inducibility. Physicians should be aware of the frequent coexistence of outflow ventricular arrhythmias and AVNRT and therefore be careful before attributing palpitations occurring after a successful VT ablation to arrhythmia recurrence. Although we elected to ablate the slow pathway in patients with inducible but not previously documented AVNRT, the question whether this is mandatory remains unsettled. Acknowledgment: We thank Serge Barold, M.D., for his helpful comments. References 1. Castellanos A Jr, Azan l, Calvino JM. Simultaneous tachycardias. Am Heart J 1960; 59:358–373. 2. Halkin H, Kaplinsky E. Simultaneous tachycardias associated with acute myocardial infarction. Chest 1971; 60:394–396. 3. Motté G, Sebag C, Belhassen B, Vaysse J, Welti JJ. Les bitachycardies. Arch Mal Coeur Vaiss 1980; 73:336–348. 4. Belhassen B, Pelleg A, Paredes A, Laniado S, Simultaneous AV nodal reentrant and ventricular tachycardias. Pacing Clin Electrophysiol 1984; 7:325–331. 5. Mann DE, Marmont P, Shultz J, Reiter MJ. Atrioventricular nodal PACE, Vol. 29 reentrant tachycardia initiated by catecholamine-induced ventricular tachycardia. A case report. J Electrocardiol 1991; 24:191–195. 6. Wagshal AB, Mittleman RS, Schuger CD, Huang SKS. Coincident idiopathic left ventricular tachycardia and atrioventricular nodal reentrant tachycardia: Control by radiofrequency ablation of the slow atrioventricular nodal pathway. Pacing Clin Electrophysiol 1994; 17:386–396. 7. Zardini M, Boyle N, Josephson ME. Coexistent narrow and wide QRS complex tachycardia: An interesting duo. Pacing Clin Electrophysiol 1996; 19:363–366. January 2006 27 TOPILSKI, ET AL. 8. Washizuka T, Niwano S, Tsuchida K, Aizawa Y. AV reentrant and idiopathic double tachycardias: Complicated interactions between two tachycardias. Heart 1999; 81:318–320. 9. Cooklin M, McComb JM. Tachycardia induced tachycardia: Case report of right ventricular outflow tract tachycardia and AV nodal reentrant tachycardia. Heart 1999; 81:321–322. 10. Kautzner J, Cihak R, Vancura V, Bytesnik J. Coincidence of idiopathic ventricular outflow tract tachycardia and atrioventricular nodal reentrant tachycardia. Europace 2003; 5:215– 220. 11. Otomo K, Wang Z, Lazzara R, Jackman WM. Atrioventricular nodal reentrant tachycardia: Electrophysiological characteristics of four forms and implications for the reentrant circuit. In: Zipes DP, Jalife J (eds.) Cardiac Electrophysiology. From Cell to Bedside, 28 3rd Ed. Philadelphia, W.B. Saunders Company, 2000, pp. 504– 521. 12. Josephson ME. Clinical Cardiac Electrophysiology. Techniques and Interpretations, 3rd Ed. Philadelphia, Lippincott Williams & Wilkins, 2002, p. 264. 13. McGuire MA, de Bakker JMT, Vermeulen JT, Opthof T, Becker AE, Janse MJ. Atrioventricular junctional tissue: Discrepancy between histological and electrophysiological characteristics. Circulation 1996; 94:571–577. 14. Antzelevitch C, Sicouri S, Lukas A. Clinical implications of electrical heterogeneity in the heart: The electrophysiology and pharmacology of epicardial, M, and endocardial cells. In: Podrid PJ, Kowey PR (eds.), Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management. Baltimore, Williams and Wilkins, 1995, pp. 88–107. January 2006 PACE, Vol. 29